By Dr. Gary Kaplan

Gkaplan-150x150

Heinrich SC, Leite-Morris KA, Guy MD, Goldberg LR, Young AJ, Kaplan GB. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction, Behav Brain Res, in press.

Nic Dhonnchadha BÁ, Lin A, Leite-Morris KA, Kaplan GB, HY Man and KM Kantak. Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning.  Behav Brain Res 238:119-23, 2013 http://www.ncbi.nlm.nih.gov/pubmed/23085477

Harte CB, Liverant GI, Sloan DM,  Kamholz BW, Rosebrock LE, Fava M, Kaplan GB. Association between smoking and heart rate variability among individuals with depression, Ann Behav Med, 2013. DOI 10.1007/s12160-013-9476-8  http://www.ncbi.nlm.nih.gov/pubmed/23436273

Nic Dhonnchadha BÁ, Lovascio BF; Shrestha N; Lin A, Leite-Morris KA, Man HY, Kaplan, GB, Kantak KM. Changes in expression of c-Fos protein following cocaine-cue extinction learning. Behavioural Brain Res 234: 100– 106, 2012  http://www.ncbi.nlm.nih.gov/pubmed/22721675

Tidey JW, Rohesenow DJ, Kaplan GB, Swift RM, AhnAllen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 15(1):121-9, 2013 http://www.ncbi.nlm.nih.gov/pubmed/22517190

AhnAllen CG, Liverant GL, Gregor K, Kamholz BW, Levitt JA, Gulliver SB, Pizzagalli DA, Kaplan GB. Heavier smokers with schizophrenia show decreased reward learning in a probabilistic reward task.  Psychiatry Research, Psychiatry Research 196(1):9-14, 2012

Kaplan GB, Leite-Morris KA, Fan WY, Young AJ, Guy MD. Opiate sensitization induces FosB/FosB expression in prefrontal cortical, striatal and amygdala brain regions. PLoS One 6(8):e23574, 2011 http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0023574

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology, 217(2):279-87, 2011 http://www.ncbi.nlm.nih.gov/pubmed/21475970

Kaplan GB and Moore KA. The use of cognitive enhancers in animal models of fear extinction.  Pharmacol Biochem Behav, 99:217-28, 2011 http://www.ncbi.nlm.nih.gov/pubmed/21256147

Kaplan GB, Heinrichs S, Carey RC.  Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications, Pharmacol Biochem Behav 97:619–625, 2011 http://www.ncbi.nlm.nih.gov/pubmed/20723558